European Medical Journal

Pioneering a New Concept for Neurology and Multiple Sclerosis – Biosimilar Natalizumab: Interview with Two Key Opinion Leaders

Biosimilar natalizumab (Tyruko) is approved by EMA, US FDA, MHRA etc. and article is intended only for the HCP audience in ...